Skip to main content
  • English
  • Français
  • About Us
    • About Us
    • Our Purpose and Identity
    • Integrated Report 2021
    • Governance
      • Governance
      • Board of Directors
      • Executive Committee
    • Where we are
    • Through time
    • All Our Stories
      • All Our Stories
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
  • Your Health
    • Your Health
    • Health and Well-Being
    • Diabetes and Cardiovascular Diseases
    • Specialty Care
      • Specialty Care
      • Rare Diseases
      • Rare Blood Disorders
      • Neurology
      • Immunology
      • Oncology
        • Oncology
        • When Cancer Grows Old
          • When Cancer Grows Old
          • Contributions Initiative
          • Global collaboration
      • Patient Support
    • Vaccines
      • Vaccines
      • The Value of vaccines
      • How immunization works
      • Infection Disease and Vaccine
        • Infection Disease and Vaccine
        • COVID-19
        • Influenza
        • Meningococcal Meningitis
        • Pertussis
        • Poliomyelitis
        • Respiratory Syncytial Virus
        • Discover more
      • Research and Innovation
      • Vaccines Production
      • Vaccines Stories
  • Science & Innovation
    • Science & Innovation
    • Partnering
      • Partnering
      • Let's partner
      • Areas of Interests
        • Areas of Interests
        • China & Emerging Markets
        • Consumer Healthcare
        • Digital
        • General Medicine
        • Immunology
        • Neuroscience
        • Oncology
        • Out-licensing
        • Rare Diseases
        • Technology Platforms
        • Vaccines
      • Meet the team
    • Research & Development
      • Research & Development
      • Sanofi Pipeline
      • Vaccines
      • Immunology and Inflammation
      • Neurology
      • Oncology
      • Pioneering Technology Platforms
        • Pioneering Technology Platforms
        • Genomic Medicine Technology Platform
        • mRNA Technology: Vaccines and Beyond
        • NANOBODY® Technology Platform
        • SYNTHORIN™ Technology Platform
      • Rare Blood Disorders R&D
      • Rare Diseases
      • Voices from the Lab
    • Clinical Trials & Results
      • Clinical Trials & Results
      • Phases
      • Our disclosure commitments
        • Our disclosure commitments
        • Sanofi Pharma
        • Sanofi Genzyme
        • Sanofi Pasteur
      • Our data sharing commitments
      • Managed Access Programs (MAPs)
      • Investigator Sponsored Studies and Externally Sponsored Collaboration
    • Science Stories
  • Our Responsibility
    • Our Responsibility
    • Environmental sustainability
    • Diversity, Equity and Inclusion
      • Diversity, Equity and Inclusion
      • Making an Impact
      • Board & Employee Groups
      • Gender Balance
        • Gender Balance
        • Women@Sanofi
      • Our Partners
      • Our LGBTQ+ Voice
    • Healthcare for all
      • Healthcare for all
      • Sanofi Humanitarian Aid Programs
      • Contributing to the eradication, elimination and control of some infectious diseases
      • Fighting Against Falsified Medicine
      • Serving the needs of patients with non-communicable diseases
    • Corporate Citizenship
    • Foundation S (Endowment Fund)
    • Ethics & Transparency
      • Ethics & Transparency
      • Code of Ethics
    • Suppliers
    • Document center
      • Document center
      • All factsheets
      • Access to Healthcare and Pricing
      • Country reports and other documents
      • CSR Strategy and Value Creation
      • Environment
      • Duty of Vigilance incl. Supply Chain
      • Ethics & Transparency
      • Governance, Controls and Procedures
      • Reporting Frameworks and Indicators
      • Social incl. Communities
  • |
  • Careers
    • Careers
    • Explore our career opportunities
    • A range of possibilities
      • A range of possibilities
      • Market access
      • Marketing
      • Medical
      • Production
      • Research & Development
      • Consumer Healthcare
      • Vaccines careers
      • Student / Graduate / Young Professionals
      • Discover more possibilities
    • Grow with us
      • Grow with us
      • Diversity & Inclusion
      • Development opportunity: how Sanofi empowers you
      • Benefits
  • Investors
    • Investors
    • Company overview
      • Company overview
      • Sanofi at a glance
      • Strategy
      • Environmental, Social, Governance
      • Financial reporting center & Key data
      • Fixed income
    • Financial results and events
      • Financial results and events
      • Financial calendar
      • Quarterly earnings at a glance
      • Investor presentations
      • Annual General Meetings
      • Broker conferences
    • Sanofi share and ADRs
      • Sanofi share and ADRs
      • Share overview
        • Share overview
        • Shares & voting rights
        • Share repurchases
      • Sanofi stock chart
      • Shareholding calculator
      • Dividends
      • ADRs
      • Shareholding structure
      • Vara consensus
    • Corporate governance
      • Corporate governance
      • Governance
      • Board of Directors
      • Executive Committee
      • Specialist committees
      • Compensations
      • Standards & rules
      • Regulated agreements
      • Internal Control
    • Individual Shareholders
      • Individual Shareholders
      • Welcome to Sanofi
      • Being a shareholder
        • Being a shareholder
        • Five reasons to be a Sanofi shareholder
        • How to buy Sanofi shares
        • Registered shares
      • Shareholder events
        • Shareholder events
        • Financial Calendar
        • Annual General Meetings
        • Participate in General Meetings
      • Reports and publications
        • Reports and publications
        • Financial and CSR reports
        • Shareholder publications
      • Shareholders committee
    • Reports and publications
      • Reports and publications
      • Financial and CSR reports
      • Shareholder publications
    • Regulated information
    • Contacts
  • Media
    • Media
    • Press releases
      • Press releases
      • 2022
        • 2022
        • Media Update: Patient enrollment of phase III tolebrutinib trials paused in the U.S.
      • 2021
      • 2020
      • 2019
      • 2018
    • Articles
      • Articles
      • 2019
    • Contacts
    • Media Alert
Worldwide
EN
  • EN
  • FR

Science Stories

  • Home
  • Science & Innovation
  • Science Stories

Cancer Under Siege

  • SCIENCE & INNOVATION
June 2, 2022

Vaccines and Monoclonal Antibodies in Immunization

  • SCIENCE & INNOVATION
February 16, 2022

We're On Track to Lead in Immunoscience

  • SCIENCE & INNOVATION
February 3, 2022

From Wearables to "Invisibles": We’re Collaborating to Study Itch in Sleeping Children

  • SCIENCE & INNOVATION
December 13, 2021

New Technologies Aim to Repair and Restore Balance in the Blood

  • SCIENCE & INNOVATION
December 9, 2021
Multiple slcerosis

Targeting Neuroinflammation in Multiple Sclerosis

  • SCIENCE & INNOVATION
October 13, 2021

Responsive Innovation in Metastatic Breast Cancer Research

  • SCIENCE & INNOVATION
October 13, 2021

Behind Sanofi’s mRNA Vaccine Candidate

September 28, 2021

A Timeline of Innovation in Hemophilia Treatment

  • SCIENCE & INNOVATION
July 16, 2021

Sanofi's Multi-Front Attack on Cancer

  • SCIENCE & INNOVATION
May 20, 2021

Clinical Trials Can Make Anyone a Hero

  • SCIENCE & INNOVATION
May 20, 2021

The Value of Industry-Academic Collaboration

  • SCIENCE & INNOVATION
May 6, 2021
Naimish Patel, Sanofi

The Next Breath: Advancing Knowledge to Transform Asthma Care

  • SCIENCE & INNOVATION
May 5, 2021

Accelerating Genomic Medicine at Sanofi

  • SCIENCE & INNOVATION
March 15, 2021

Gene Therapy at a Glance

  • SCIENCE & INNOVATION
March 15, 2021

How Registries Accelerate Rare Disease Research

  • SCIENCE & INNOVATION
March 12, 2021
Scientist in a laboratory

Sanofi Oncology: Looking Ahead

  • SCIENCE & INNOVATION
February 4, 2021

Taking Down Type 2 Inflammatory Disease

  • SCIENCE & INNOVATION
November 30, 2020

REGAINing Control of Asthma

  • SCIENCE & INNOVATION
November 30, 2020
Stock image: 3D illustration of cell

One Pathway, Many Rare Diseases

  • SCIENCE & INNOVATION
October 16, 2020

The Science Behind Sanofi's Hemophilia Pipeline

  • SCIENCE & INNOVATION
September 10, 2020
logo Upshot Series

Vaccines: our best line of defense against infectious diseases like COVID-19

  • YOUR HEALTH
July 27, 2020
Karin Knobe

Inside Sanofi’s Hemophilia Research

  • ABOUT US
July 10, 2020
Lung Cancer

Identifying a New Target to Address an old challenge: CEACAM5 and Lung Cancer

  • ABOUT US
June 15, 2020

Supporting Scientific Progress Through Clinical Trials

  • ABOUT US
May 20, 2020

Sanofi Researchers Turn a Hunch into a Clinical Study for Rare Diseases

  • SCIENCE & INNOVATION
February 24, 2020
Covid-19

Sanofi’s Commitment to Fighting COVID-19

  • #SANOFIACTS

Voices from the Lab

  • SCIENCE & INNOVATION

How immunization works?

  • VALUE OF VACCINES
Small molecule protein degrader

Targeting Estrogen Receptors in Metastatic Breast Cancer

  • SCIENCE & INNOVATION
Sanofi

    Follow us

  • Contact
  • Legal notice
  • Privacy & Data Protection
  • Cookies policy
  • Corporate code of ethics
  • Our publications
  • Sitemap
  • Our websites
  • Accessibility: partial compliance

© Sanofi 2004-2022 - All rights reserved

You are about to leave sanofi.com

If you wish to continue to this external website, click Proceed.

It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.

PROCEED